Evaluation of novel cell cycle inhibitors in mantle cell lymphoma

Keyphrases

• Cell Cycle Inhibitors 100%
• Mantle Cell Lymphoma 100%
• Sulfone 100%
• Styryl 100%
• Cytotoxicity 33%
• Doxorubicin 33%
• Apoptosis 16%
• Cyclin 16%
• Kinase Inhibitor 16%
• B-cell Lymphoma 16%
• Targeted Therapy 16%
• Molecular Analysis 16%
• Lymphoma Cells 16%
• Transferases 16%
• End-labelling 16%
• Poly(ADP-ribose) Polymerase 16%
• Cyclin D 16%
• Novel Class 16%
• Apoptotic Pathway 16%
• Murine Double Minute 2 (MDM2) 16%
• Pyrimidine 16%
• Related Compounds 16%
• Purine 16%
• Caspase-3 Activity 16%
• Uridine Triphosphate 16%
• New Drug Development 16%
• Polymerase Assay 16%
• Cell Cycle Pathway 16%
• Cyclin B 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Mantle Cell Lymphoma 100%
• Sulfone 100%
• Doxorubicin 33%
• Vincristine 33%
• Cytotoxicity 33%
• Drug Development 16%
• B Cell Lymphoma 16%
• Caspase 3 16%
• Transferase 16%
• Protein P53 16%
• Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 16%
• Cycline 16%
• Cyclin D 16%
• Purine Derivative 16%
• Phosphotransferase Inhibitor 16%
• Uridine Triphosphate 16%
• Pyrimidine Derivative 16%
• Cyclin B 16%
• Protein MDM2 16%